for post exposure prophylaxis for rabies for uniform and effective treatment protocol. It is sincerely hoped that the guideline will be of immense use for better management of animal bite cases and availability and affordability of modern rabies vaccine for all through introduction of cost-effective multisite Intradermal (ID) schedule for post-exposure rabies prophylaxis.
Materials and Methods:
An expert group was formed by CDC of DGHS, Mohakhali, Dhaka to formulate the guideline. The participants in the group included expertise on rabies management, practitioners managing anti-rabies clinic, laboratory medicine practitioners, policy makers, public health experts from both public and private sector. Repeated brainstorming meetings were done by the expert groups. Extensive literature was searched through Pubmed and Other search engine (e.g-google) to accommodate the materials. The expertise from different countries (Thailand, Srilanka, India, philipines etc) were also helped through online for formulating the nation based papers. All WHO papers on rabies were critically appraised and recent recommendation from international seminar, symposium ( e.g-Bali Recommendation, Jan 2010) were also keep before making final recommendation for national guideline. Extended meeting in abroad (In Thailand) with expertise were also done before drafting the national guideline. Considering the recommendations of experts, results of clinical trials and international experience, experts of Bangladesh recommends this national guideline. The draft paper was critically appraised in different meeting and also presented in front of the National Technical Working Group(NTWG) of Rabies control programme,2010. The final recommendation was done in final meeting of Rabies control programme in IEDCR, Dhaka in June,2010. The final copy is endorsed by the Ministry of Health, Bangladesh to be used for Health care providers of Bangladesh.
Results and Discussion:
In rabies endemic country like Bangladesh, where animal rabies control programme is non-existent, every animal bite is potentially suspected as a rabid animal bite. Hence the management should be immediate, complete and comprehensive. Because of long incubation period, it is possible to institute post-exposure prophylaxis (PEP).WHO has given guide to PEP management for endemic countries 8 . To bring out uniformity globally, the classification of animal bite for post-exposure prophylaxis has been based on WHO recommendations (Table 1) .
Management of animal bite wound (Table-II):
Since the rabies virus enters the human body through a bite or scratch, it is imperative to remove as much saliva, and thereby the virus, from the wound as is possible by an efficient wound toilet that should not involve additional trauma. Since the rabies virus can persist and even multiply at the site of bite for a long time, wound toilet must be performed even if the patient reports late 9.10 . ** Post exposure prophylaxis should be considered when contact between a human and a bat occurred unless the exposed person can rule out a bite or scratch, or exposure to mucous membrane. It is re-emphasized that post exposure prophylaxis should be started as early as possible after exposure. However, it should not be denied to person reporting late for treatment as explained previously 
Rabies Immunoglobulins (RIG):
The anti-rabies serum/rabies immunoglobulin provides passive immunity in the form of ready-made anti-rabies antibody to tide over the initial phase of the infection. Antirabies serum or RIG has the property of binding with the rabies virus, thereby resulting in the loss of infectivity of the virus. Two types of RIGs are available and recommended to use: a. Equine Rabies Immunoglobulins (ERIG) and b. Human Rabies Immunoglobulins (HRIG).
Dose of rabies immunoglobulins:
Equine rabies immunoglobulins(ERIG):40 IU per kg body weight upto a maximum of 3000 IU. Human rabies immunoglobulins (HRIG): 20 IU per kg body weight (maximum 1500 IU).
Indication of RIG and importance: 11 
•
All category III exposures, irrespective of status of biting animal.
• Administer even when treatment is delayed but RIGs should not be given after 7 days of start of vaccination (3rd dose ARV administered)
• Immunoglobulins (HRIG /ERIG) are life saving when timely used.
• There is no substitute for RIG and all other options are inferior.
Administration of RIG:
As much of the calculated dose of RIG as is anatomically feasible should be infiltrated into and around the wounds (site of bite).Multiple needle injections into the wound should be avoided. Remaining, if any, after all wounds have been infiltrated, should be administered by deep intramuscular injection at an injection site distant from the vaccine injection site. Immunoglobulin should never be administered in the same syringe or at the same anatomical site All emergency drugs and facilities for managing any adverse reactions must be available. RIG should be administered before starting antirabies vaccination. RIG should not be administered in the same syringe (fig 3) as the vaccine or at the same site as vaccine. While infiltrating RIG into bite wounds, care must be taken to avoid injecting into blood vessels and nerves. Anatomical feasibility must always be kept in mind while injecting RIG. While injecting into finger tips, care must be taken to avoid compartment syndrome. In small children with multiple bites, if the volume is insufficient for infiltration in and around all wounds, dilute RIG with sterile N. saline up to double or 3 times. Pregnancy is not a contra-indicated for RIG and anti-rabies vaccination when indicated. Keep the patient under observation for at least one hour after ERIG administration and send home. The treating physician should be prepared to manage anaphylaxis which could occur at any stage of administration of ERIG irrespective of the outcome of the skin sensitivity test.
Sensitivity test before administration of ERIG 11,12 : ERIG must be administered only after the Test dose.
Test dose (ERIG) : Follow the Manufacturer Guidelines or Inject 0.1 ml of 1:10 dilution of the ERIG in normal saline, Intra Dermally over flexor aspect of forearm. A negative skin test must never reassure the physician that no anaphylactic reaction will occur.
Observe
Positive test reaction (Fig 2)
Ø Induration >10mm with or without constitutional symptoms.
Ø If skin test is positive -HRIG is preferred (affordability, availability)
Ø If ERIG has to be administered then pre treat with Adrenaline / Epinephrine and with Antihistamine before administering full dose. 
Management if anaphylactic reaction occurs:
1. Adrenaline: The dose is 0.5 ml of 0.1 percent solution (1 in 1000, 1mg/ml) for adults and 0.01 ml/kg body weight for children, injected intramuscularly(IM).
Active Immun ization:
Rabies Biologicals: Rabies vaccines induce an active immune response that includes the production of virus neutralizing antibodies. The active antibody response requires approximately 7-10 days to develop, and detectable rabies virus neutralizing antibodies generally persist for several years.
• Two types of vaccines to protect against rabies in humans exist - Active immunization is achieved by administration of safe and potent CCVs. In Bangladesh, NTV is still used for postexposure treatment in public sector. However, as this vaccine is reactogenic, the production will be stopped soon. Privately, CCVs are now used for active immunization. Very soon CCV will be available in public sector too.
Indications: All age groups of animal bite victims of Category II and III require the same number of injections and dose per injection. The Category III exposures, in addition require administration of rabies immunoglobulins as discussed earlier.
Storage and transportation: Though most Cell Culture
Vaccines are marketed in freeze dried (lyophilised) form which is more tolerant of vagaries of temperature, yet it is recommended that these vaccines should be kept and transported at a temperature range of 2-8ºC. Freezing does not damage the lyophilised vaccine but there are chances of breakage of ampoule containing the diluent.
Liquid vaccines of nerve tissue or cell culture origin should never be frozen. Reconstitution and storage:
The lyophilised vaccine should be reconstituted with the diluent provided with the vaccine immediately prior to use. However, in case of unforeseen delay it should not be used after 6-8 hours of reconstitution.
Precaution: Immunosuppression like Corticosteroids, other immunosuppressive agents, antimalarials, and immunosuppressive illnesses can interfere with the development of active immunity after vaccination. immunosuppressed persons who are at risk for rabies should have their virus neutralizing antibody titers checked after completing the pre-exposure. Pregnancy is not considered a contraindication to postexposure prophylaxis. If the risk for exposure to rabies is substantial, pre-exposure prophylaxis also might be indicated during pregnancy. Persons who have a history of serious hypersensitivity to components of rabies vaccine or to other vaccines with components that are also present in rabies vaccine should be revaccinated with caution
Protective level of anti-rabies antibody:
Humoral antibodies play important role in protection against rabies and a titre of 0.5 IU/ml or more in serum as tested by Rapid Fluorescent Focus Inhibition Test (RFFIT) is considered as protective.Currently available CCVs could be administered by IM regimen or approved CCVs could be administered by ID regimen
Intra-muscular (IM) Regimen
The currently available vaccines and regimen in Bangladesh for IM administration are described below.
Vaccines: Cell Culture Vaccines • Purified Vero Cell Rabies Vaccine (PVRV) • Purified Chick Embryo Cell Vaccine (PCEC)

Regimen (fig 4)
Zagreb schedule:
Four doses/Three visits (2-1-1) intramuscular regimen (DO, D7, D21)
In the abbreviated multisite schedule, the 2-1-1 regimen, one dose is given in the right arm and one dose in the left arm at day 0, and one dose applied in the deltoid muscle on days 7 and 21. The 2-1-1 schedule induces an early antibody response and may be particularly effective when postexposure treatment does not include administration of rabies immunoglobulin. be used as soon as possible, but within 6 hours. All the reconstituted vaccines should be discarded after 6 hours of reconstitution and at the end of the day.Rabies vaccines formulated with an adjuvant should not be administered intradermally. Vaccine when given intra-dermally should raise a visible and palpable bleb in the skin.In the event that the dose is inadvertently given subcutaneously or intramuscularly or in the event of spillage, a new dose should be given intra-dermally in near by site.Only medical practitioners and health professionals who have completed short training course on application of ID schedule for rabies prophylaxis are permitted to use ID schedule.
I/D schedule is not recommended for immunocompromised patients (patients on cytotoxic drugs, on long term steroids, positive for HIV/AIDS, on anti-malarial and biologics).
Vaccines :
• Intradermal regimens consist of administration of a fraction of intramuscular dose of certain Cell
Culture rabies vaccine on multiple sites in the layers of dermis of skin.
The vaccines used are same; however route, dose and site of administration differ. The use of intra-dermal route leads to considerable savings in terms of total amount of vaccine needed for full pre-or post-exposure vaccination, thereby reducing the cost of active immunisation. While using ID route, small amount (0.1ml) of rabies vaccines/antigen is deposited in the layers of the skin at multiple sites. The antigen is directly presented to the antigen presenting cells (with out circulation/dilution in blood) at multiple sites triggering a stronger immune response. Intra-dermal injections must be administered by staff trained in this technique. Vaccine vials must be stored at 2º to 8ºC after reconstitution. The total content of reconstituted vial should If re-exposed, persons who have previously received full post-exposure prophylaxis (either by IM or ID route) with a potent cell-culture vaccine within last five years should now be given only two booster doses, intramuscularly (0.5ml/ 1ml)/intra-dermally (0.1 ml at 1 site) on days 0 and 3 14 . Proper wound toilet should be done. RIG application is not necessary. In re-exposed case where person who have not received complete course of PEP by IM/ID route within 5 yrs or not sure about the number of doses, a complete PEP courses should be applied. After five years animal bite case will be treated as a fresh case. 
